Neuromuscular

Mitochondrial DNA-related cardiomyopathy and hearing loss

ORPHA:1349 ↗Gene MT-TKMalformation syndrome

1

studies recruiting now

as of 7 Sept 2026

1

studies registered in total

as of 7 Sept 2026

2

countries with a recruiting site

as of 7 Sept 2026

15 Feb 2013

most recent study posted

among recruiting studies

Recruiting trials

Showing the 1 most recently updated recruiting study, as recorded 7 Sept 2026. Live status on each study page.

Search all Mitochondrial DNA-related cardiomyopathy and hearing loss studies

Where recruiting studies are running

Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.

Keep watching

Get an email when a new Mitochondrial DNA-related cardiomyopathy and hearing loss study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

About Mitochondrial DNA-related cardiomyopathy and hearing loss

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (MT-TK).

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).